NORML
APRIL 8, 2020
Under existing regulations, the agency only licenses one facility — the University of Mississippi — to cultivate cannabis for use in FDA-approved clinical trials. In 2016, the agency appeared to reconsider its longstanding policy, and publicly stated for the first time that it would consider additional applicants.
NORML
AUGUST 2, 2019
A federal court has ordered the Drug Enforcement Administration to respond to a lawsuit charging the agency with failing to move forward with a 2016 policy to expand the total number of federally licensed marijuana cultivators. On July 29, the Appellate Court ordered to provide a written response to the filing with 30 days.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
MARCH 26, 2020
In a Notice of Proposed Rulemaking , published this week in the Federal Register , the agency acknowledges its longstanding failure to act upon the 35 bulk cultivation applications before it. Those entities who wish to either cultivate low-THC crops (those containing no more than 0.3
NORML
AUGUST 26, 2019
According to the agency’s filing today in the Federal Register, the DEA “intends to promulgate regulations” to evaluate several dozen applications before it from private entities that wish to cultivate cannabis for FDA-approved research. However, this is not the first time the agency has made such a promise.
NORML
JULY 6, 2023
Seven years after California voters passed Proposition 64 in 2016, successfully legalizing marijuana possession, cultivation, and sales, the courts are finally nearly finished relieving all qualifying cannabis cases. The post California Addresses 90% of Cannabis Cases in Expungement Efforts appeared first on NORML.
NORML
MAY 13, 2019
Voters initially approved medical cannabis access by passing a statewide initiative in November 2016. Products must be derived from plants harvested by one of five state-licensed cultivators. To date, only one cultivator is operational. Two additional cultivators are expecting to harvest their initial crops this summer.
NORML
OCTOBER 21, 2019
A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis. The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials.
Expert insights. Personalized for you.
354 
Let's personalize your content